Metformin, a drug linked with the regulation of the glucose metabolism in patients with diabetes type 2, has been shown to impulse the tumor surveillance through the maintenance of induction of effector/memory CD8+ T cells [153]. The gene discussed is CD8A; the disease is neoplasm.